INS and type 2 diabetes mellitus: There is an ongoing trial to assess the effectiveness of pioglitazone in treating advanced liver disease due to its insulin sensitizing effects, while lifestyle modification is a rational and safe therapy for MASLD with T2DM (236, 237).